Eosinophilia-myalgia syndrome

[1]  B. Thompson,et al.  Wheezing on maximal forced exhalation in the diagnosis of atypical asthma. Lack of sensitivity and specificity. , 2020, Annals of Internal Medicine.

[2]  M. Osterholm,et al.  An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. , 1990, The New England journal of medicine.

[3]  J. Duffy,et al.  The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. , 1990, Annals of internal medicine.

[4]  B. Kang,et al.  Nonwheezing bronchial asthma diagnosed by methacholine challenge. , 1990, The American journal of medicine.

[5]  E. Sternberg,et al.  Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. , 1990, The New England journal of medicine.

[6]  D. E. Nelson,et al.  Interim guidance on the eosinophilia-myalgia syndrome. , 1990, Annals of internal medicine.

[7]  W. Nauseef,et al.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. , 1989, The New England journal of medicine.

[8]  L. Holinger.  Chronic cough in infants and children , 1986, The Laryngoscope.

[9]  J. Curnutte.  Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system. , 1985, The Journal of clinical investigation.

[10]  R. M. Smith,et al.  Molecular basis of chronic granulomatous disease. , 1991, Blood.